October 18, 2021
PAR-21-213 - Urgent Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed)
NOT-AG-21-056 - Notice of Change of Award Type and further Clarifications to PAR-21-213 "Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed)"
NOT-NR-21-007 - Notice of Participation of NINR in PAR-21-213, “Urgent Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed)”
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
This Notice announces the participation of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), effective immediately, in Funding Opportunity Announcement (FOA) PAR-21-213, “Urgent Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed)".
The following sections of PAR-21-213 have been modified to reflect the NICHD participation in this FOA:
Currently Reads:
Part 1. Overview Information
Components of Participating Organizations
National Institute on Aging (NIA)
National Eye Institute (NEI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
National Institute on Minority Health and Health Disparities (NIMHD)
National Institute of Nursing Research (NINR)
All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.
Office of Behavioral and Social Sciences Research (OBSSR)
Office of Research on Women's Health (ORWH)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.866, 93.867, 93.313, 93.273, 93.279, 93.307, 93.242
Modified to Read (changes shown in bold italics):
Part 1. Overview Information
Components of Participating Organizations
National Institute on Aging (NIA)
National Eye Institute (NEI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
National Institute on Minority Health and Health Disparities (NIMHD)
National Institute of Nursing Research (NINR)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.
Office of Behavioral and Social Sciences Research (OBSSR)
Office of Research on Women's Health (ORWH)
Assistance Listing Number(s)
93.866, 93.867, 93.313, 93.273, 93.279, 93.307, 93.242, 93.361, 93.865
Further, the orginal FOA is edited to add the NICHD-specific Funding Opportunity Description:
Part 2. Full Text of Announcement
Section I. Funding Opportunity Description
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) supports research, training, health information dissemination, and other programs with respect to gynecologic health, maternal health, child health, intellectual disabilities, human growth and development, including prenatal development, population research, and special health problems and requirements of mothers and children.
For this FOA, NICHD is interested in grant applications that examine the impacts of the COVID-19 pandemic on the social determinants of health and the health of underserved and health disparities populations.
NICHD priorities include:
Among the COVID-19 medically and/or socially vulnerable populations, NICHD prioritizes the following groups: individuals with intellectual, developmental, or physical disabilities, individuals involved with the juvenile justice systems (incarcerated or under community supervision); children with parents involved with the criminal justice system; individuals with HIV/AIDS; pregnant and post-partum women; children and adolescents; individuals in overcrowded or public housing; immigrants and the children of immigrants; residents of tribal lands or reservations; individuals exposed to high rates of air pollution or other toxic exposures; and individuals who reside in rural and remote communities.
Because NICHD is already making substantial investments to the Safe Return to School Diagnostic Testing Initiative, NICHD will not be prioritizing research on return to school submitted through this funding announcement. See NOT-OD-21-065, Notice of Intent to Publish a Research Opportunity Announcement for RADx-UP Return to School Diagnostic Testing Approaches (OT2 Clinical Trial Optional); NOT-OD-21-072, Notice of Correction to NOT-OD-21-065 "Notice of Intent to Publish a Research Opportunity Announcement for RADx-UP Return to School Diagnostic Testing Approaches (OT2 Clinical Trial Required)" for Clinical Trial Requirements; NOT-OD-21-097, Notice of Intent to Publish a Research Opportunity Announcement for RADx-UP Return to School Diagnostic Testing Approaches (OT2 Clinical Trial Optional)
Section VII. Agency Contacts
Scientific/Research Contact(s)
Rebecca L. Clark, Ph.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-496-1175
Email: [email protected]
Financial/Grants Management Contact(s)
Teri Pailen
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-979-0142
Email: [email protected]
All other aspects of the FOA remain unchanged.
Rebecca L. Clark, Ph.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
301-496-1175
[email protected]